The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Epidemiology, Risk Factors, and Natural History of Hepatocellular Carcinoma
Abstract
A bstract: The incidence of hepatocellular carcinoma is increasing in many countries. The estimated number of new cases annually is over 500,000, and the yearly incidence comprises between 2.5 and 7% of patients with liver cirrhosis. The incidence varies between different geographic areas, being higher in developing areas; males are predominantly affected, with a 2:3 male/female ratio. The heterogeneous geographic distribution reflects the epidemiologic impact of the main etiologic factors and environmental risk, which are the hepatitis B (HBV) and hepatitis C (HCV) viruses. The percentage of cases of hepatocellular carcinoma attributable to HBV worldwide is 52.3% and is higher in Asia where the seroprevalence of HBsAg in the population is high. However, the vaccination campaign against this virus in some eastern countries has tended to lower the incidence of new cases of hepatocellular carcinoma. The percentage of cases of hepatocellular carcinoma attributable to HCV is 25%, and it is more prevalent in Japan, Spain, and Italy where the association between hepatocellular carcinoma and antibodies to HCV ranges between 50 and 70%. In most cases hepatocellular carcinoma develops in cirrhotic livers, where the persistent proliferation of liver cells represents the key factor of progression to hepatocellular carcinoma independent of the etiology. Another minor risk factor is aflatoxin B1 consumption, which is responsible for most cases of hepatocellular carcinoma in Africa, where the consumption of contaminated foods is common. Other known risk factors are some hereditary diseases, such as hemochromatosis, porphyria cutanea tarda, hereditary tyrosinemia, and α 1 anti‐trypsin deficiency. The natural history of hepatocellular carcinoma is heterogeneous and is influenced by nodule dimension, the mono‐ or plurifocality of lesions at diagnosis, the growth rate of the tumor, and the stage of the underlying cirrhosis. Available data to date suggest that tumor growth in a cirrhotic liver is variable and that the time in which a lesion in undetectable until it becomes 2 cm is between 4 and 12 months. Therefore, the suggested interval for surveillance screening with ultrasound in patients with liver cirrhosis has been set at 6 months. Patients who should benefit from screening programs are those who would be treated with curative therapy if diagnosed with hepatocellular carcinoma. Thus, the ideal target population should be limited to Child‐Pugh's class A cirrhotic patients without significant comorbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Estimates of the worldwide incidence of 25 major cancers in 1990
Parkin, Pisani, P., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990315)80:6<827::aid-ijc6>3.0.co;2-p · Cited by 2,037
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
Llovet, J. M., Bustamante, J., Castells, A., Vilana, R., Del Carmen Ayuso, M., Sala, M., Brú, C., Rodés, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510290145 · Cited by 1,190
Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease
Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282501 · Cited by 1,126
Epidemiology of Primary Liver Cancer
Bosch, F., Ribes, J., & Borràs, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007117 · Cited by 958
Bruix, J., Calvet, X., Costa, J., Ventura, M., Bruguera, M., Castillo, R., María Barrera, J., Ercilla, G., María Sanchez-Tapias, J., Vall, M., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91015-5 · Cited by 734
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Colombo, M., Choo, Q. L., Del Ninno, E., Dioguardi, N., Kuo, G., Donato, M. F., Tommasini, M. A., & Houghton, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91016-7 · Cited by 666
Cancer and infection: estimates of the attributable fraction in 1990.
Pisani, P., Parkin, D. M., Muñóz, N., & Ferlay, J. (1997) · PubMed · Cited by 448
Okuda, K. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80428-6 · Cited by 443
TREATMENT OF ALCOHOLISM WITH A SENSITISING DRUG
Martensen-Larsen, O. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91515-3 · Cited by 442
Takano, S., Yokosuka, O., Imazeki, F., Tagawa, M., & Omata, M. (1995) · Hepatology · doi:10.1002/hep.1840210308 · Cited by 432
Ebara, M., Ohto, M., Shinagawa, T., Sugiura, N., Kimura, K., Matsutani, S., Morita, M., Saisho, H., Tsuchiya, Y., & Okuda, K. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90923-6 · Cited by 394
Hepatitis C Virus Genotypes and Risk of Hepatocellular Carcinoma in Cirrhosis: A Prospective Study
Bruno, S., Silini, E., Crosignani, A., Borzio, F., Leandro, G., Bono, F., Asti, M., Rossi, S., Larghi, A., Cerino, A., et al. (1997) · Hepatology · doi:10.1002/hep.510250344 · Cited by 358
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis
Liaw, Y.-F., Tai, D.-I., Chu, C.-M., Lin, D.-Y., Sheen, I.-S., Chen, T.-J., & Pao, C. C. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90919-4 · Cited by 309
Toxicological evaluation of certain food additives
(1979) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(79)90333-x · Cited by 299
HCV-associated liver cancer without cirrhosis
De Mitri, M. S., Pisi, E., Poussin, K., Paterlini, P., Bréchot, C., Baccarini, P., D'Errico, A., Grigiani, W., Alberti, A., Pontisso, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90400-x · Cited by 294
The Natural History of Asymptomatic Hepatitis B Surface Antigen Carriers
de Franchis, R., Meucci, G., Vecchi, M., Tatarella, M., Colombo, M., Del Ninno, E., Rumi, M. G., Donato, M. F., & Ronchi, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00006 · Cited by 292
Livraghi, T., Bolondi, L., Buscarini, L., Cottone, M., Mazziotti, A., Morabito, A., & Torzilli, G. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80445-5 · Cited by 278
McMahon, B. J. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.5.1051 · Cited by 273
Nishioka, K., Watanabe, J., Furuta, S., Tanaka, E., Iino, S., Suzuki, H., Tsuji, T., Yano, M., Kuo, G., Choo, Q., et al. (1991) · Cancer · doi:10.1002/1097-0142(19910115)67:2<429::aid-cncr2820670218>3.0.co;2-# · Cited by 238
Villa, E., Moles, A., Ferretti, I., Buttafoco, P., Grottola, A., Del Buono, M., De Santis, M., & Manenti, F. (2000) · Hepatology · doi:10.1053/jhep.2000.9603 · Cited by 224
Borzio, M., Bruno, S., Roncalli, M., Colloredo Mels, G., Ramella, G., Borzio, F., Leandro, G., Servida, E., & Podda, M. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90455-7 · Cited by 218
Ganne-Carrie, N., Chastang, C., Chapel, F., Munz, C., Pateron, D., Sibony, M., Deny, P., Trinchet, J., Callard, P., Guettier, C., et al. (1996) · Hepatology · doi:10.1002/hep.510230527 · Cited by 206
McMahon, B. J. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390170087019 · Cited by 201
Sergi, C., Adam, S., Kahl, P., & Otto, H. F. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)81188-5 · Cited by 189
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A case-control study
Silini, E., Bottelli, R., Asti, M., Bruno, S., Candusso, M., Brambilla, S., Bono, F., Iamoni, G., Tinelli, C., Mondelli, M., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8698200 · Cited by 179
Benvegnù, L. (1997) · Hepatology · doi:10.1053/jhep.1997.v25.pm0008985292 · Cited by 152
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study
Jf, T., Jeng, J., Ho, M., Chang, W., Hsieh, M., Lin, Z., & Tsai, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.493 · Cited by 144
Campbell, T. C., Chen, J., Liu, C. B., Li, J. Y., & Parpia, B. (1990) · PubMed · Cited by 110
Tradati, F., Colombo, M., Mannucci, P. M., Rumi, M. G., Fazio, C., Gamba, G., CIAVARELLA, N., Rocino, A., Morfini, M., Scaraggi, A., et al. (1998) · PubMed · Cited by 105
Tanaka, K., Ikematsu, H., Hirohata, T., & Kashiwagi, S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.11.742 · Cited by 74
Progression of hepatitis B and C to hepatocellular carcinoma in Western countries.
Fattovich, G. (1998) · PubMed · Cited by 60
Cited by
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Venook, A. P., Papandreou, C., Furuse, J., & Ladrón de Guevara, L. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-05 · Cited by 965
Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
Gomaa, A. I., Khan, S. A., Toledano, M. B., Waked, I., & Taylor-Robinson, S. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4300 · Cited by 700
Steelman, L. S., Chappell, W. H., Abrams, S. L., Kempf, C. R., Long, J., Laidler, P., Mijatovic, S., Maksimovic-Ivanic, D., Stivala, F., Mazzarino, M. C., et al. (2011) · Aging · doi:10.18632/aging.100296 · Cited by 553
Self-citationMixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients
Ferri, C., Sebastiani, M., Giuggioli, D., Cazzato, M., Longombardo, G., Antonelli, A., Puccini, R., Michelassi, C., & Zignego, A. L. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2003.10.001 · Cited by 528
Metadata
- Authors
- MONTALTO, G., CERVELLO, M., GIANNITRAPANI, L., DANTONA, F., TERRANOVA, A., & CASTAGNETTA, L. A. M.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2002-06
- Volume
- 963
- Issue
- 1
- Pages
- 13-20
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W1999152495
- Cited by
- 312
- References
- 38
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.